Skip to main
VTR

Ventas (VTR) Stock Forecast & Price Target

Ventas (VTR) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 13%
Buy 67%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Ventas maintains a robust and diversified healthcare portfolio, consisting of nearly 1,400 properties across senior housing, medical office, hospitals, life sciences, and skilled nursing/post-acute care, which positions the company favorably in the healthcare real estate investment trust (REIT) sector. The firm's strategic presence in Canada and the United Kingdom, alongside its focus on investment opportunities in mature healthcare systems similar to the United States, enhances its growth potential and geographic diversification. Additionally, with approximately 1% of its net operating income derived from mortgages and other loans, Ventas demonstrates a balanced approach to revenue generation, contributing to its positive financial outlook despite competitive pressures in the healthcare asset market.

Bears say

Ventas faces a negative outlook primarily due to potential reductions in Medicare and Medicaid reimbursements, which could adversely affect its rent coverage ratios and lead to rent restructuring or reductions. The company has significant tenant concentration, with revenue exposure exceeding 5% from individual tenants, making it vulnerable to financial difficulties stemming from reimbursement rate changes. Additionally, the firm's reliance on capital markets for growth in a rising interest rate environment raises concerns about its ability to maintain or expand its portfolio, especially given the bond-like cash flows typically associated with healthcare REITs.

Ventas (VTR) has been analyzed by 15 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 67% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ventas and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ventas (VTR) Forecast

Analysts have given Ventas (VTR) a Buy based on their latest research and market trends.

According to 15 analysts, Ventas (VTR) has a Buy consensus rating as of Jan 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $78.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $78.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ventas (VTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.